rs796052159

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4BP6

The NM_002006.6(FGF2):​c.326G>A​(p.Gly109Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000925 in 1,081,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 9.2e-7 ( 0 hom. )

Consequence

FGF2
NM_002006.6 missense

Scores

2
5
11

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.105

Publications

1 publications found
Variant links:
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.36319542).
BP6
Variant 4-122827101-G-A is Benign according to our data. Variant chr4-122827101-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 207863.Status of the report is no_assertion_criteria_provided, 0 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002006.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FGF2
NM_001361665.2
MANE Select
c.-74G>A
5_prime_UTR
Exon 1 of 3NP_001348594.1D9ZGF5
FGF2
NM_002006.6
c.326G>Ap.Gly109Asp
missense
Exon 1 of 3NP_001997.5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FGF2
ENST00000264498.9
TSL:1
c.326G>Ap.Gly109Asp
missense
Exon 1 of 3ENSP00000264498.4P09038-4
FGF2
ENST00000644866.2
MANE Select
c.-74G>A
5_prime_UTR
Exon 1 of 3ENSP00000494222.1P09038-2
FGF2
ENST00000608478.1
TSL:1
c.-74G>A
5_prime_UTR
Exon 1 of 3ENSP00000477134.1P09038-2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
9.25e-7
AC:
1
AN:
1081124
Hom.:
0
Cov.:
31
AF XY:
0.00000195
AC XY:
1
AN XY:
514006
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
21724
American (AMR)
AF:
0.00
AC:
0
AN:
7326
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13256
East Asian (EAS)
AF:
0.00
AC:
0
AN:
23916
South Asian (SAS)
AF:
0.0000385
AC:
1
AN:
25994
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22812
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2822
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
920580
Other (OTH)
AF:
0.00
AC:
0
AN:
42694
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Long QT syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Uncertain
0.080
D
BayesDel_noAF
Benign
-0.12
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.36
T
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.43
T
M_CAP
Pathogenic
0.71
D
MetaRNN
Benign
0.36
T
MetaSVM
Benign
-0.60
T
MutationAssessor
Benign
0.34
N
PhyloP100
-0.10
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-0.37
N
REVEL
Uncertain
0.36
Sift
Uncertain
0.0060
D
Sift4G
Uncertain
0.0090
D
Polyphen
0.99
D
MutPred
0.32
Gain of solvent accessibility (P = 0.0281)
MVP
0.80
ClinPred
0.83
D
GERP RS
2.1
PromoterAI
-0.051
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.23
gMVP
0.13
Mutation Taster
=289/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs796052159; hg19: chr4-123748256; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.